Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Chromosomal Recombination Targets in Chlamydia Interspecies Lateral Gene Transfer.

Suchland RJ, Carrell SJ, Wang Y, Hybiske K, Kim DB, Dimond ZE, Hefty PS, Rockey DD.

J Bacteriol. 2019 Nov 5;201(23). pii: e00365-19. doi: 10.1128/JB.00365-19. Print 2019 Dec 1.

PMID:
31501285
2.

Development of Transposon Mutagenesis for Chlamydia muridarum.

Wang Y, LaBrie SD, Carrell SJ, Suchland RJ, Dimond ZE, Kwong F, Rockey DD, Hefty PS, Hybiske K.

J Bacteriol. 2019 Nov 5;201(23). pii: e00366-19. doi: 10.1128/JB.00366-19. Print 2019 Dec 1.

PMID:
31501283
3.

Transposon Mutagenesis in Chlamydia trachomatis Identifies CT339 as a ComEC Homolog Important for DNA Uptake and Lateral Gene Transfer.

LaBrie SD, Dimond ZE, Harrison KS, Baid S, Wickstrum J, Suchland RJ, Hefty PS.

MBio. 2019 Aug 6;10(4). pii: e01343-19. doi: 10.1128/mBio.01343-19.

4.

Genetic Screen in Chlamydia muridarum Reveals Role for an Interferon-Induced Host Cell Death Program in Antimicrobial Inclusion Rupture.

Giebel AM, Hu S, Rajaram K, Finethy R, Toh E, Brothwell JA, Morrison SG, Suchland RJ, Stein BD, Coers J, Morrison RP, Nelson DE.

MBio. 2019 Apr 9;10(2). pii: e00385-19. doi: 10.1128/mBio.00385-19.

5.
6.

Interrogating Genes That Mediate Chlamydia trachomatis Survival in Cell Culture Using Conditional Mutants and Recombination.

Brothwell JA, Muramatsu MK, Toh E, Rockey DD, Putman TE, Barta ML, Hefty PS, Suchland RJ, Nelson DE.

J Bacteriol. 2016 Jul 13;198(15):2131-9. doi: 10.1128/JB.00161-16. Print 2016 Aug 1.

7.

Culture-independent sequence analysis of Chlamydia trachomatis in urogenital specimens identifies regions of recombination and in-patient sequence mutations.

Putman TE, Suchland RJ, Ivanovitch JD, Rockey DD.

Microbiology. 2013 Oct;159(Pt 10):2109-17. doi: 10.1099/mic.0.070029-0. Epub 2013 Jul 10.

8.

Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants.

Jeffrey BM, Suchland RJ, Eriksen SG, Sandoz KM, Rockey DD.

BMC Microbiol. 2013 Jun 20;13:142. doi: 10.1186/1471-2180-13-142.

9.

Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.

Sandoz KM, Eriksen SG, Jeffrey BM, Suchland RJ, Putman TE, Hruby DE, Jordan R, Rockey DD.

Antimicrob Agents Chemother. 2012 Aug;56(8):4296-302. doi: 10.1128/AAC.00356-12. Epub 2012 May 29.

10.

Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype.

Lutter EI, Bonner C, Holland MJ, Suchland RJ, Stamm WE, Jewett TJ, McClarty G, Hackstadt T.

Infect Immun. 2010 Sep;78(9):3678-88. doi: 10.1128/IAI.00515-10. Epub 2010 Jul 6.

11.

Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination.

Jeffrey BM, Suchland RJ, Quinn KL, Davidson JR, Stamm WE, Rockey DD.

Infect Immun. 2010 Jun;78(6):2544-53. doi: 10.1128/IAI.01324-09. Epub 2010 Mar 22.

12.

Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.

Suchland RJ, Sandoz KM, Jeffrey BM, Stamm WE, Rockey DD.

Antimicrob Agents Chemother. 2009 Nov;53(11):4604-11. doi: 10.1128/AAC.00477-09. Epub 2009 Aug 17.

13.

Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.

Rothstein DM, Suchland RJ, Xia M, Murphy CK, Stamm WE.

J Antibiot (Tokyo). 2008 Aug;61(8):489-95. doi: 10.1038/ja.2008.65.

PMID:
18997387
14.

Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Suchland RJ, Jeffrey BM, Xia M, Bhatia A, Chu HG, Rockey DD, Stamm WE.

Infect Immun. 2008 Dec;76(12):5438-46. doi: 10.1128/IAI.00984-08. Epub 2008 Oct 13.

15.

Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection.

Campbell LA, Kuo CC, Suchland RJ, Rothstein DM.

Antimicrob Agents Chemother. 2008 May;52(5):1855-8. doi: 10.1128/AAC.01567-07. Epub 2008 Mar 10.

16.

Clonal isolation of chlamydia-infected cells using flow cytometry.

Alzhanov DT, Suchland RJ, Bakke AC, Stamm WE, Rockey DD.

J Microbiol Methods. 2007 Jan;68(1):201-8. Epub 2006 Sep 25.

PMID:
16997404
18.

Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.

Suchland RJ, Brown K, Rothstein DM, Stamm WE.

Antimicrob Agents Chemother. 2006 Feb;50(2):439-44.

19.

Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response.

Xia M, Suchland RJ, Bumgarner RE, Peng T, Rockey DD, Stamm WE.

J Infect Dis. 2005 Oct 1;192(7):1229-36. Epub 2005 Aug 25.

PMID:
16136466
20.

Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.

Xia M, Suchland RJ, Carswell JA, Van Duzer J, Buxton DK, Brown K, Rothstein DM, Stamm WE.

Antimicrob Agents Chemother. 2005 Sep;49(9):3974-6.

21.

Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Suchland RJ, Rockey DD, Weeks SK, Alzhanov DT, Stamm WE.

Infect Immun. 2005 Jul;73(7):3954-62.

22.

Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.

Suchland RJ, Bourillon A, Denamur E, Stamm WE, Rothstein DM.

Antimicrob Agents Chemother. 2005 Mar;49(3):1120-6.

23.

Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates.

Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D, Maclean I, Mohammed Z, Peeling R, Roshick C, Schachter J, Solomon AW, Stamm WE, Suchland RJ, Taylor L, West SK, Quinn TC, Belland RJ, McClarty G.

J Clin Invest. 2003 Jun;111(11):1757-69.

24.

Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996.

Suchland RJ, Eckert LO, Hawes SE, Stamm WE.

Sex Transm Dis. 2003 Apr;30(4):357-61.

PMID:
12671559
25.

The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection.

Geisler WM, Suchland RJ, Whittington WL, Stamm WE.

Sex Transm Dis. 2003 Feb;30(2):160-5. Review.

PMID:
12567176
26.

Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

Suchland RJ, Geisler WM, Stamm WE.

Antimicrob Agents Chemother. 2003 Feb;47(2):636-42.

27.

Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy non-fusogenic inclusions.

Rockey DD, Viratyosin W, Bannantine JP, Suchland RJ, Stamm WE.

Microbiology. 2002 Aug;148(Pt 8):2497-505.

PMID:
12177343
28.
29.
30.

Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions.

Geisler WM, Suchland RJ, Rockey DD, Stamm WE.

J Infect Dis. 2001 Oct 1;184(7):879-84. Epub 2001 Aug 22.

PMID:
11528595
31.

Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping.

Dean D, Suchland RJ, Stamm WE.

J Infect Dis. 2000 Sep;182(3):909-16. Epub 2000 Aug 17.

PMID:
10950788
32.

Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race.

Eckert LO, Suchland RJ, Hawes SE, Stamm WE.

J Infect Dis. 2000 Aug;182(2):540-4. Epub 2000 Jul 21.

PMID:
10915086
33.
34.

Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men.

Boisvert JF, Koutsky LA, Suchland RJ, Stamm WE.

Sex Transm Dis. 1999 Aug;26(7):392-8.

PMID:
10458633
35.
36.
37.

Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar.

Workowski KA, Stevens CE, Suchland RJ, Holmes KK, Eschenbach DA, Pettinger MB, Stamm WE.

Clin Infect Dis. 1994 Oct;19(4):756-60.

PMID:
7803644
39.

Association of genital infection with specific Chlamydia trachomatis serovars and race.

Workowski KA, Suchland RJ, Pettinger MB, Stamm WE.

J Infect Dis. 1992 Dec;166(6):1445-9.

PMID:
1431263
40.

Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline.

van der Willigen AH, van Rijsoord-Vos T, Wagenvoort JH, Stamm WE, Suchland RJ, Stolz E.

Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):561-3. No abstract available.

PMID:
1526246
41.
42.

[Serotype distribution of urogenitally located Chlamydia trachomatis in Rotterdam].

Wagenvoort JH, Suchland RJ, van Rijsoort-Vos T, Stamm WE.

Ned Tijdschr Geneeskd. 1989 Sep 30;133(39):1936-9. Dutch.

PMID:
2797314
43.

Detection of different Chlamydia trachomatis serovars of urogenital origin by enzyme-immunoassay.

Wagenvoort JH, Suchland RJ, Kluijtmans JA, Stamm WE.

Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):319-20. No abstract available.

PMID:
2469578
44.

Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands.

Wagenvoort JH, Suchland RJ, Stamm WE.

Genitourin Med. 1988 Jun;64(3):159-61.

45.

Rapid diagnosis of Chlamydia trachomatis rectal infection by direct immunofluorescence staining.

Rompalo AM, Suchland RJ, Price CB, Stamm WE.

J Infect Dis. 1987 May;155(5):1075-6. No abstract available.

PMID:
3549919
46.

Detection of multiple serovars of Chlamydia trachomatis in genital infections.

Barnes RC, Suchland RJ, Wang SP, Kuo CC, Stamm WE.

J Infect Dis. 1985 Nov;152(5):985-9.

PMID:
3840190

Supplemental Content

Loading ...
Support Center